Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Seasonality of antidepressant prescriptions and sick leaves.

Winkler D, Reichardt B, Kranz GS, Bartova L, Kasper S, Pjrek E.

J Psychiatr Res. 2019 Jan 26;111:128-133. doi: 10.1016/j.jpsychires.2019.01.020. [Epub ahead of print]

PMID:
30738345
2.

Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study.

Meyer BM, Rabl U, Huemer J, Bartova L, Kalcher K, Provenzano J, Brandner C, Sezen P, Kasper S, Schatzberg AF, Moser E, Chen G, Pezawas L.

Transl Psychiatry. 2019 Feb 4;9(1):64. doi: 10.1038/s41398-019-0395-8.

3.

Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression.

Dold M, Bartova L, Kautzky A, Porcelli S, Montgomery S, Zohar J, Mendlewicz J, Souery D, Serretti A, Kasper S.

J Clin Psychiatry. 2019 Jan 15;80(1). pii: 17m12090. doi: 10.4088/JCP.17m12090.

PMID:
30677267
4.

Implementing prevention of seasonal affective disorder from patients' and physicians' perspectives - a qualitative study.

Nussbaumer-Streit B, Pjrek E, Kien C, Gartlehner G, Bartova L, Friedrich ME, Kasper S, Winkler D.

BMC Psychiatry. 2018 Nov 26;18(1):372. doi: 10.1186/s12888-018-1951-0.

5.

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples.

Fabbri C, Kasper S, Kautzky A, Bartova L, Dold M, Zohar J, Souery D, Montgomery S, Albani D, Raimondi I, Dikeos D, Rujescu D, Uher R, Lewis CM, Mendlewicz J, Serretti A.

Br J Psychiatry. 2019 Jan;214(1):36-41. doi: 10.1192/bjp.2018.256. Epub 2018 Nov 23.

PMID:
30468137
6.

Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study.

Dold M, Bartova L, Kautzky A, Serretti A, Porcelli S, Souery D, Mendlewicz J, Montgomery S, Zohar J, Kasper S.

Eur Neuropsychopharmacol. 2018 Dec;28(12):1305-1313. doi: 10.1016/j.euroneuro.2018.10.003. Epub 2018 Nov 13.

PMID:
30446357
7.

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.

Kautzky A, Dold M, Bartova L, Spies M, Kranz GS, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Dikeos D, Rujescu D, Kasper S.

Acta Psychiatr Scand. 2019 Jan;139(1):78-88. doi: 10.1111/acps.12959. Epub 2018 Oct 5.

PMID:
30291625
8.

Rapid antidepressant effect of S-ketamine in schizophrenia.

Bartova L, Papageorgiou K, Milenkovic I, Dold M, Weidenauer A, Willeit M, Winkler D, Kasper S.

Eur Neuropsychopharmacol. 2018 Aug;28(8):980-982. doi: 10.1016/j.euroneuro.2018.05.007. Epub 2018 Jul 2.

PMID:
30041987
9.

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.

Caraci F, Calabrese F, Molteni R, Bartova L, Dold M, Leggio GM, Fabbri C, Mendlewicz J, Racagni G, Kasper S, Riva MA, Drago F.

Pharmacol Rev. 2018 Jul;70(3):475-504. doi: 10.1124/pr.117.014977. Review.

PMID:
29884653
10.

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).

Dold M, Bartova L, Fugger G, Kautzky A, Souery D, Mendlewicz J, Papadimitriou GN, Dikeos D, Ferentinos P, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S.

Int J Neuropsychopharmacol. 2018 Jun 1;21(6):539-549. doi: 10.1093/ijnp/pyy009.

11.

Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD).

Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S.

Eur Neuropsychopharmacol. 2018 Jun;28(6):752-760. doi: 10.1016/j.euroneuro.2018.03.011. Epub 2018 Apr 26.

PMID:
29705022
12.

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.

Dold M, Bartova L, Mendlewicz J, Souery D, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S.

Acta Psychiatr Scand. 2018 May;137(5):401-412. doi: 10.1111/acps.12870. Epub 2018 Feb 28.

13.

Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample.

Kautzky A, Dold M, Bartova L, Spies M, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Kasper S.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 16m11385. doi: 10.4088/JCP.16m11385.

PMID:
29228516
14.

Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study.

Dold M, Bartova L, Souery D, Mendlewicz J, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S.

J Affect Disord. 2018 Feb;227:254-259. doi: 10.1016/j.jad.2017.10.033. Epub 2017 Oct 28.

PMID:
29107818
15.

Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials.

Dold M, Bartova L, Rupprecht R, Kasper S.

Psychother Psychosom. 2017;86(5):283-291. doi: 10.1159/000477770. Epub 2017 Sep 14.

PMID:
28903107
16.

The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study.

Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S.

Eur Neuropsychopharmacol. 2017 Jul;27(7):625-632. doi: 10.1016/j.euroneuro.2017.05.004. Epub 2017 May 31.

PMID:
28579072
17.

Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.

Bartova L, Weidenauer A, Dold M, Naderi-Heiden A, Kasper S, Willeit M, Praschak-Rieder N.

J ECT. 2017 Sep;33(3):e31-e32. doi: 10.1097/YCT.0000000000000421. No abstract available.

PMID:
28520578
18.

Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study.

Dold M, Bartova L, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S.

J Psychiatr Res. 2017 Aug;91:1-13. doi: 10.1016/j.jpsychires.2017.02.020. Epub 2017 Feb 27.

PMID:
28284107
19.

Administration of ketamine for unipolar and bipolar depression.

Kraus C, Rabl U, Vanicek T, Carlberg L, Popovic A, Spies M, Bartova L, Gryglewski G, Papageorgiou K, Lanzenberger R, Willeit M, Winkler D, Rybakowski JK, Kasper S.

Int J Psychiatry Clin Pract. 2017 Mar;21(1):2-12. doi: 10.1080/13651501.2016.1254802. Epub 2017 Jan 18. Review. Erratum in: Int J Psychiatry Clin Pract. 2017 Jun;21(2):161.

PMID:
28097909
20.

Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study.

Dold M, Kautzky A, Bartova L, Rabl U, Souery D, Mendlewicz J, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S.

Eur Neuropsychopharmacol. 2016 Dec;26(12):1960-1971. doi: 10.1016/j.euroneuro.2016.10.005. Epub 2016 Nov 2.

PMID:
27816317
21.

Making Sense of: Sensitization in Schizophrenia.

Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Praschak-Rieder N, Sitte HH, Kasper S, Willeit M.

Int J Neuropsychopharmacol. 2016 Dec 31;20(1):1-10. doi: 10.1093/ijnp/pyw081. Print 2017 Jan. Review.

22.

Bipolar II disorder as a risk factor for postpartum depression.

Mandelli L, Souery D, Bartova L, Kasper S, Montgomery S, Zohar J, Mendlewicz J, Serretti A.

J Affect Disord. 2016 Nov 1;204:54-8. doi: 10.1016/j.jad.2016.06.025. Epub 2016 Jun 14.

PMID:
27327115
23.

Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases.

Bartova L, Vogl SE, Stamenkovic M, Praschak-Rieder N, Naderi-Heiden A, Kasper S, Willeit M.

Eur Neuropsychopharmacol. 2015 Nov;25(11):2183-4. doi: 10.1016/j.euroneuro.2015.07.021. Epub 2015 Aug 6.

PMID:
26302763
24.

Reduced default mode network suppression during a working memory task in remitted major depression.

Bartova L, Meyer BM, Diers K, Rabl U, Scharinger C, Popovic A, Pail G, Kalcher K, Boubela RN, Huemer J, Mandorfer D, Windischberger C, Sitte HH, Kasper S, Praschak-Rieder N, Moser E, Brocke B, Pezawas L.

J Psychiatr Res. 2015 May;64:9-18. doi: 10.1016/j.jpsychires.2015.02.025. Epub 2015 Mar 6.

25.

Oppositional COMT Val158Met effects on resting state functional connectivity in adolescents and adults.

Meyer BM, Huemer J, Rabl U, Boubela RN, Kalcher K, Berger A, Banaschewski T, Barker G, Bokde A, Büchel C, Conrod P, Desrivières S, Flor H, Frouin V, Gallinat J, Garavan H, Heinz A, Ittermann B, Jia T, Lathrop M, Martinot JL, Nees F, Rietschel M, Smolka MN, Bartova L, Popovic A, Scharinger C, Sitte HH, Steiner H, Friedrich MH, Kasper S, Perkmann T, Praschak-Rieder N, Haslacher H, Esterbauer H, Moser E, Schumann G, Pezawas L.

Brain Struct Funct. 2016 Jan;221(1):103-14. doi: 10.1007/s00429-014-0895-5. Epub 2014 Oct 16.

26.

Additive gene-environment effects on hippocampal structure in healthy humans.

Rabl U, Meyer BM, Diers K, Bartova L, Berger A, Mandorfer D, Popovic A, Scharinger C, Huemer J, Kalcher K, Pail G, Haslacher H, Perkmann T, Windischberger C, Brocke B, Sitte HH, Pollak DD, Dreher JC, Kasper S, Praschak-Rieder N, Moser E, Esterbauer H, Pezawas L.

J Neurosci. 2014 Jul 23;34(30):9917-26. doi: 10.1523/JNEUROSCI.3113-13.2014.

27.

The spectral diversity of resting-state fluctuations in the human brain.

Kalcher K, Boubela RN, Huf W, Bartova L, Kronnerwetter C, Derntl B, Pezawas L, Filzmoser P, Nasel C, Moser E.

PLoS One. 2014 Apr 11;9(4):e93375. doi: 10.1371/journal.pone.0093375. eCollection 2014.

28.

Platelet serotonin transporter function predicts default-mode network activity.

Scharinger C, Rabl U, Kasess CH, Meyer BM, Hofmaier T, Diers K, Bartova L, Pail G, Huf W, Uzelac Z, Hartinger B, Kalcher K, Perkmann T, Haslacher H, Meyer-Lindenberg A, Kasper S, Freissmuth M, Windischberger C, Willeit M, Lanzenberger R, Esterbauer H, Brocke B, Moser E, Sitte HH, Pezawas L.

PLoS One. 2014 Mar 25;9(3):e92543. doi: 10.1371/journal.pone.0092543. eCollection 2014.

29.

Brain-derived neurotrophic factor: a peripheral biomarker for major depressive disorder and antidepressant efficacy?

Scharinger C, Bartova L, Pezawas L.

Per Med. 2011 Mar;8(2):115-117. doi: 10.2217/pme.11.9. No abstract available.

PMID:
29783402
30.

Is there a personalized medicine for mood disorders?

Bartova L, Berger A, Pezawas L.

Eur Arch Psychiatry Clin Neurosci. 2010 Nov;260 Suppl 2:S121-6. doi: 10.1007/s00406-010-0152-8. Epub 2010 Oct 19. Review.

PMID:
20957381
31.

[The capacity of fusicoccin for inducing the synthesis of early interferon].

Amchenkova AM, Narovlianskiĭ AN, Cheknev SB, Bartova LM, Kulagina NN.

Zh Mikrobiol Epidemiol Immunobiol. 2005 Jul-Aug;(4):80-2. Russian.

PMID:
16146236
32.

[Capacity of fusicoccin for inducing the production of early interferon].

Amchenkova AM, Narovlianskiĭ AN, Cheknev SB, Bartova LM, Kulagina NN.

Zh Mikrobiol Epidemiol Immunobiol. 2005 Mar-Apr;(2):69-71. Russian.

PMID:
15881944
33.

Endogenous fusicoccin-like ligand revealed in higher plants by radioreceptor and radioimmunoassays.

Babakov AV, Bartova LM, Margulis GU, Oganyan RR, Voblikova VD, Maisuryan AN, Dridze IL, Muromtsev GS.

FEBS Lett. 1994 Sep 5;351(2):243-5.

34.

[Involvement of fibronectin and serum components interacting with it in regulating the activity of human natural killer cells].

Cheknev SB, Kuiavskaia DV, Tarkhanova IA, Babaeva EE, Bartova LM, Kul'berg AIa.

Biull Eksp Biol Med. 1994 Jul;118(7):54-9. Russian. No abstract available.

PMID:
7522620
35.

[Level of R-proteins in blood during development of diabetes mellitus].

Fedotov VP, Chernushkina AV, Shcherbacheva LN, Bartova LM, Kulagina NN, Kul'berg AIa.

Vopr Med Khim. 1991 Mar-Apr;37(2):40-2. Russian.

PMID:
1897191
36.

Herpes simplex virus antibodies in the cerebrospinal fluid of schizophrenic patients.

Bártová L, Rajcáni J, Pogády J.

Acta Virol. 1987 Sep;31(5):443-6.

PMID:
2891284
37.

[Results of virology research in organic and functional psychoses].

Rajcáni J, Bartová L, Kúdelová M, Libíková H, Pogády J.

Bratisl Lek Listy. 1987 Aug;88(2):137-48. Slovak. No abstract available.

PMID:
2889513
38.

[The role of A-cells in affecting the immunostimulating effect of F(ab')2-fragments].

Bartova LM, Margulis GU, Kulagina NN, Kul'berg AIa.

Biull Eksp Biol Med. 1986 May;101(5):589-91. Russian.

PMID:
3708145
39.

[Prognosis of surgical wound infection].

Kalashnik AF, Kul'berg AIa, Bartova LM, Bialik IF.

Sov Med. 1983;(2):22-5. Russian. No abstract available.

PMID:
6857339
40.

[Determination of the titer of pepsin agglutinin (homoreactant) for the evaluation of the course of acute pneumonia].

Lutoshkin SF, Sil'vestrov VP, Bartova LM, Kul'berg AIa, Reznikov IuP.

Ter Arkh. 1982;54(9):50-2. Russian. No abstract available.

PMID:
6817433
41.

Studies of Fc receptors of heart valve and joint fibroblasts.

Danilova TA, Bartova LM, Panurina RL, Lyampert IM.

Clin Exp Immunol. 1981 Dec;46(3):575-80.

42.

[Possibility of predicting wound suppuration based on data on the content of the antiglobulin factor, pepsin agglutinator].

Kalashnik AF, Kul'berg AIa, Bartova LM.

Ortop Travmatol Protez. 1980 Nov;(11):9-11. Russian. No abstract available.

PMID:
6782534
43.

[Pepsin homoreactant titer in premature newborns normally and in infectious, inflammatory diseases].

Tabolin VA, Iartsev MN, Kul'berg AIa, Bartova LM, Tatarskaia GS.

Pediatriia. 1980;(1):19-21. Russian. No abstract available.

PMID:
6770333
44.

[Differences in the properties of antibodies and natural antiglobulin-homoreactants revealed by the method of human IgG chemical modification].

Fishevskaia EV, Bartova LM, Kil'bere AIa.

Biull Eksp Biol Med. 1979 Nov;88(11):585-7. Russian.

PMID:
94269
45.

[Reactions of normal human and rabbit immunoglobulins with heart valve fibroblasts].

Danilova TA, Bartova LM, Beglarian AA, Panurina RL.

Biull Eksp Biol Med. 1979 Jun;87(6):564-6. Russian.

PMID:
465688
47.

[Ability of FAB-fragments of normal rabbit and human gamma globulins to suppress human lymphocyte blast transformation induced by phytomitogens].

Kul'berg AIa, Baranova FS, Margulis GU, Popova LK, Bartova LM.

Biull Eksp Biol Med. 1977 Aug;84(8):178-81. Russian.

PMID:
71170
48.

[Pepsin homoreactant (agglutinator) in patients with rheumatoid arthritis and other rheumatic diseases].

Mirakhmedova AKh, Bartova LM, Tarkhanova IA, Kul'berg AIa, Trofimova TM.

Sov Med. 1977 Jul;(7):15-9. Russian. No abstract available.

PMID:
331491
49.

[Comparative analysis of the adjuvant action of fab-fragments of normal rabbit IgG obtained using pepsin and papain].

Evnin DN, Kul'berg AIa, Bartova LM.

Biull Eksp Biol Med. 1977 Jan;83(1):48-50. Russian.

PMID:
322754
50.

Comparative immunological studies of IgG and naturally occurring anti-globulin factors to pepsin and papain fragments of homologous IgG.

Kulberg AJ, Bartova LM, Tarkhanova IA, Reznikow JP, Jusupova-Redai S.

Clin Immunol Immunopathol. 1976 Jul;6(1):13-21. No abstract available.

PMID:
780024

Supplemental Content

Loading ...
Support Center